Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
10.1038/nm1632
Saved in:
Main Authors: | Patil, S.T., Zhang, L., Martenyi, F., Lowe, S.L., Jackson, K.A., Andreev, B.V., Avedisova, A.S., Bardenstein, L.M., Gurovich, I.Y., Morozova, M.A., Mosolov, S.N., Neznanov, N.G., Reznik, A.M., Smulevich, A.B., Tochilov, V.A., Johnson, B.G., Monn, J.A., Schoepp, D.D. |
---|---|
Other Authors: | INSTITUTE OF MOLECULAR & CELL BIOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/114986 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
MGlu receptors
Published: (2020) -
Effects of a novel mGlu 2/3 receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid
by: Lowe, S., et al.
Published: (2014) -
A high throughput enzyme-linked immunosorbent assay for inhibitors of the interaction between retinoblastoma protein and the Leu-X-Cys-X-Glu motif
by: Ellsmore, V.A., et al.
Published: (2014) -
Colorability of glued graphs
by: Chanon Promsakon
Published: (2011) -
THE GLUING OPERATION IN GAUGE THEORY
by: DAI BO
Published: (2019)